lobbying_activities: 1262680

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1262680	29214ecf-1260-4c3d-928f-e74f59eac9e2	Q2	SQUIRE PATTON BOGGS	30906	GENENTECH, INC.	2012	second_quarter	MED	Implementation of healthcare reform law. FDA drug approval and appeal oversight process. Issues related to patient and physician choice in medical treatments. PDUFA reauthorization.	HOUSE OF REPRESENTATIVES,SENATE	90000		0	0	2012-07-14T10:04:28.880000-04:00